CD56+CD3- NK cells and CD56+CD3+ NKT cells were markedly reduced in tumor tissues compared to NAT, with the decrease in NK cells reaching statistical significance (p < 0.05), while NKT cells showed a similar decreasing trend (p = 0.056) (Fig. 4, G and H). The gene discussed is BRD2; the disease is neoplasm.